If any controlled substance appears in the listed bulk database, please ignore it, as we do not supply or offer controlled substances.
Dipyridamole EP Impurity D
100% accuracy
of data
24/7 scientific
support
0% tolerance in
quality of product

Stock Locations

  • New Jersey, USA
  • Czech Republic, EU
  • Mumbai, India

* Stock subject to availability.

Documentation

Download MSDS

Download Sample COA

Includes: HPLC, MASS/LC-MS, 1H NMR, FT-IR, Potency, Structure Elucidation Report (SER), and additional analytical data depending on the product.

1176886-12-6Dipyridamole EP Impurity D

● In Stock

Catalogue No.:VL47004
CAS No.:1176886-12-6
Mol. Formula:C22H36N8O3
Mol. Weight:460.57 g/mol

Additional information on CAS 1176886-12-6

Parent drug

Dipyridamole

IUPAC Name

2,2′-[[6-[(2-hydroxyethyl)amino]-4,8-di(piperidin-1-yl)pyrimido[5,4-d]pyrimidin-2-yl]nitrilo]diethano

Synonyms

Dipyridamole Related Compound D; 2, 2′-[[6-[(2-Hydroxyethyl)amino]-4, 8-di-1-piperidinylpyrimido[5, 4-d]pyrimidin-2-yl]imino]bisethanol;

Description

Dipyridamole EP Impurity D (CAS No.: 1176886-12-6) or Dipyridamole Related Compound D is a metabolite of Dipyridamole and an antitumor nucleoside pyrimido pyrimidine. Dipyridamole is a pyrimidopyrimidine derivative that is commonly prescribed as an antiplatelet drug.

References

Fontani, F., et al. “Purity Evaluation of Dipyridamole by High-Performance Liquid Chromatography.†Journal of Chromatography A, vol. 280, Jan. 1983, pp. 181–87, https://doi.org/10.1016/s0021-9673(00)91557-7.?Oates, John A., et al. “Dipyridamole.†New England Journal of Medicine, vol. 316, no. 20, May 1987, pp. 1247–57, https://doi.org/10.1056/nejm198705143162005.

Request a Quote

"*" indicates required fields

This field is for validation purposes and should be left unchanged.
This field is hidden when viewing the form
Products quotation
Name
Url
 
This field is hidden when viewing the form
This field is hidden when viewing the form